Email Updates

You are here

MTN 005

Status
Completed
Phase
II
Principal Investigator(s)
Craig Hoesley
Objective

The purpose of this study is to evaluate the safety of and adherence to a non-medicated IVR in HIV uninfected women over 12 weeks of use.

Prevention Option(s)
Microbicides
Study Design
Controlled
Randomized
Open label
Arms and Assigned Interventions
Description
Insertion of intravaginal ring at enrollment. The intravaginal ring should stay in place for 12 consecutive weeks and will be removed by a physician at the Week 12 study visit.
Mode of Delivery
Ring
ARMs
Experimental
Description
Intravaginal ring will not be inserted into participants.
ARMs
Placebo Comparator
Trial Sponsors
Population Council, NIAID, NIMH, MTN
May 2011
September 2012
Enrollment
195
18
Years
45
Years
Population
Women
Sites

National AIDS Research Institute

Pune
India

University of Alabama at Birmingham

Birmingham, Alabama
United States of America

Bronx-Lebanon Hospital

New York, New York
United States of America